The evidence discovered recently that microdosing may be useful in treating depression is the main reason why there is the perspective to decriminalize psychedelics and make them legal at least for medical research. Along with anxiety, depression is an epidemic nowadays, and the number of people who get sick continues to rise. Many are looking for alternative, sustainable treatment methods, such as microdosing on magic mushrooms. Research that begins with cultivated magic mushroom spores has given scientists the opportunity to look at the positive impact micro dosing sometimes has on how the brain deals with depression.
Those who suffer from depression often describe that they feel “stuck” and that microdosing takes them out of this feeling of stagnation. This happens thanks to the brain’s reaction to certain psychoactive compounds in magic mushrooms. For instance, psilocybin seems to be able to regulate brain patterns behind the ego (which is the part that gives us our sense of self and our memories). Put simply, that “voice in our head” is called DMN (default mode network) and it defines who we are. We have no control over this part of our brain, so an unhealthy default mode network is often very difficult to manage, so it is likely to cause many problems.
It is known that DMN is overactive in people suffering from depression, but ingesting psilocybin gives it a break, so you can experience that state also known as “ego’s death”. It can help reduce the amount of anxiety and it may positively increase the connections with the environment. These aspects are important in dealing with depression because they offer people new perspectives on their lives.